Lipoprotein (a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease (original) (raw)

High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease

Masaaki Miyata

American Heart Journal, 1996

View PDFchevron_right

Lipoprotein(a) Level Does Not Predict Restenosis After Percutaneous Transluminal Coronary Angioplasty

Poonam Alaigh

Arteriosclerosis, Thrombosis, and Vascular Biology, 1998

View PDFchevron_right

The influence of plasma lipoprotein (a) on angiographic restenosis and coronary events in patients undergoing planned coronary balloon angioplasty Ancillary analysis of the Fluvastatin Angioplasty Restenosis (FLARE) trial

guy lloyd

Atherosclerosis, 2001

View PDFchevron_right

Plasma Lipoprotein(a) Is Not a Predictor for Restenosis After Elective High-Pressure Coronary Stenting

Valeria Ferrero

Circulation, 1998

View PDFchevron_right

Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty

D. Prisco

Atherosclerosis, 2001

View PDFchevron_right

Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids

Erik Thaulow

European Heart Journal, 1999

View PDFchevron_right

Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty

Jean-Charles Fruchart

Clinica Chimica Acta, 2000

View PDFchevron_right

Lipoprotein(a) and coronary thrombosis and restenosis after stent placement

Anne Kastrati

Journal of The American College of Cardiology, 1999

View PDFchevron_right

Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)

Bonnie Weiner, Sheryl Kelsey

2010

View PDFchevron_right

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery

Andrew Neil

Heart, 1997

View PDFchevron_right

High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis

Francesco Cuccurullo

Heart, 2003

View PDFchevron_right

Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention

Hiroyuki Daida

The American Journal of Cardiology, 2015

View PDFchevron_right

Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery

Wendy Taddei-Peters

Atherosclerosis, 1998

View PDFchevron_right

Lipoprotein(a) Changes during and after Coronary Artery Bypass Grafting: An Epiphenomenon?

Christa Cobbaert

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998

View PDFchevron_right

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease

Christina Tsitsimpikou

Experimental and Therapeutic Medicine

View PDFchevron_right

Carl Pepine

The American Journal of Cardiology, 1990

View PDFchevron_right

Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis

Alfredo Rodriguez

American Journal of Cardiology, 1993

View PDFchevron_right

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

Michael Cowley

The American Journal of Cardiology, 1984

View PDFchevron_right

Prediction of Coronary Artery Restenosis in Patients Undergoing Angioplasty

mubabol journal

Journal of Babol University of Medical Sciences, 2018

View PDFchevron_right

Lipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease

Michael Domanski

Journal of the American College of Cardiology, 2014

View PDFchevron_right

Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery

Valentin Sinitsyn

The Journal of Thoracic and Cardiovascular Surgery, 2003

View PDFchevron_right

The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction

Ender Örnek

Clinical & Investigative Medicine, 2011

View PDFchevron_right

Correlation Lipoprotein A Level with Complexity of Coronary Lesion in Coronary Heart Disease Patient at Rsup Dr. Sardjito Yogyakarta

Nahar Taufiq

Bangladesh Journal of Medical Science, 2016

View PDFchevron_right

Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty

Gilbert Gosselin

The American Journal of Cardiology, 1994

View PDFchevron_right

Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study

Sagarika Ekanayake

BMC Cardiovascular Disorders, 2016

View PDFchevron_right

Impact of restenosis 10 years after coronary angioplasty

Christine Espinola-klein

European Heart Journal, 1998

View PDFchevron_right

Clinical and quantitative coronary angiographic predictors of coronary restenosis

William Wijns

Journal of the American College of Cardiology, 2001

View PDFchevron_right

Lipoprotein (a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease (original) (raw)

Related papers